临床合理用药杂志
臨床閤理用藥雜誌
림상합리용약잡지
CHINESE JOURNAL OF CLINICAL RATIONAL DRUG USE
2015年
15期
7-8
,共2页
张守娟%韩延昭%李绵%毕青松
張守娟%韓延昭%李綿%畢青鬆
장수연%한연소%리면%필청송
脑干梗死%尿激酶型纤溶酶原激活物%胞磷胆碱钠%治疗结果
腦榦梗死%尿激酶型纖溶酶原激活物%胞燐膽堿鈉%治療結果
뇌간경사%뇨격매형섬용매원격활물%포린담감납%치료결과
Brain stem infarction%Urokinase-type plasminogen activator%Citicoline sodium%Treatment outcome
目的:探讨小剂量尿激酶联合胞磷胆碱钠治疗脑干梗死的疗效。方法选取2010年1月—2013年6月于乐亭县中医医院神经内科住院的急性脑干梗死患者30例,结合患者及家属意愿将患者分为治疗组与对照组,各15例。治疗组予以尿激酶联合胞磷胆碱钠治疗治疗,对照组予以奥扎格雷钠治疗。观察两组患者脑卒中临床神经功能缺损程度评分( NIHSS)、临床疗效及不良反应发生情况。结果治疗前两组患者NIHSS评分比较,差异无统计学意义(P>0.05),治疗后24h、14d治疗组患者NIHSS评分低于对照组,差异有统计学意义(P<0.05);治疗组患者总有效率高于对照组( P<0.05);两组患者均未发生严重不良反应。结论小剂量尿激酶联合胞磷胆碱钠治疗脑干梗死的疗效显著,可改善患者预后,且不良反应小。
目的:探討小劑量尿激酶聯閤胞燐膽堿鈉治療腦榦梗死的療效。方法選取2010年1月—2013年6月于樂亭縣中醫醫院神經內科住院的急性腦榦梗死患者30例,結閤患者及傢屬意願將患者分為治療組與對照組,各15例。治療組予以尿激酶聯閤胞燐膽堿鈉治療治療,對照組予以奧扎格雷鈉治療。觀察兩組患者腦卒中臨床神經功能缺損程度評分( NIHSS)、臨床療效及不良反應髮生情況。結果治療前兩組患者NIHSS評分比較,差異無統計學意義(P>0.05),治療後24h、14d治療組患者NIHSS評分低于對照組,差異有統計學意義(P<0.05);治療組患者總有效率高于對照組( P<0.05);兩組患者均未髮生嚴重不良反應。結論小劑量尿激酶聯閤胞燐膽堿鈉治療腦榦梗死的療效顯著,可改善患者預後,且不良反應小。
목적:탐토소제량뇨격매연합포린담감납치료뇌간경사적료효。방법선취2010년1월—2013년6월우악정현중의의원신경내과주원적급성뇌간경사환자30례,결합환자급가속의원장환자분위치료조여대조조,각15례。치료조여이뇨격매연합포린담감납치료치료,대조조여이오찰격뢰납치료。관찰량조환자뇌졸중림상신경공능결손정도평분( NIHSS)、림상료효급불량반응발생정황。결과치료전량조환자NIHSS평분비교,차이무통계학의의(P>0.05),치료후24h、14d치료조환자NIHSS평분저우대조조,차이유통계학의의(P<0.05);치료조환자총유효솔고우대조조( P<0.05);량조환자균미발생엄중불량반응。결론소제량뇨격매연합포린담감납치료뇌간경사적료효현저,가개선환자예후,차불량반응소。
Objective To explore the effect of low dose urokinase and citicolin in treating brain stem infarction. Methods A total of 30 patients with brain stem infarction were selected in the Traditional Chinese Medicine Hospital of Leting County from January 2010 to June 2013,combined with the patient and family to intend,they were divided into treatment group and control group,15 cases in each group. Treatment group were given low dose urokinase and citicolin treatment, control group given sodium ozagrel treatment. NIHSS scores,clinical effect and incidence of adverse reactions between the two groups were compared. Results Before treatment,NIHSS scores showed no significant differences between the two groups( P >0. 05),24 hours after treatment and 14 days after treatment,NIHSS scores of the treatment group was lower than that of control group(P<0. 05);the total effective rate of treatment group was higher than that of control group(P<0. 05);no one of the two groups occurred serious adverse reactions. Conclusion Low dose urokinase and citicolin has notable curative effect in the treatment of brain stem infarction,can improve the prognosis of patients and is with less adverse reactions.